ASCO 2016 | Somatic genomic landscape of advanced-stage cancer patients from clinical NGS analysis of ctDNA
Press brief by Philip Mack, PhD of the UC Davis Comprehensive Cancer Center, Sacramento, CA, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.
Get great new content delivered to your inboxSign up
A promising future for gemcitabine-oxaliplatin in cisplatin-unfit advanced urothelial carcinoma
Changing kidney cancer treatment landscape
Darolutamide for nmCRPC: results of the ARAMIS trial
COACH trial update: GemOx vs. GCb in cisplatin-unfit advanced urothelial carcinoma
Interaction of darolutamide with substrates of CYPs and P-gp